
HIV-1 drug resistance before initiation or re-initiation of first-line ART in eight regions of Mexico: a sub-nationally representative survey
Author(s) -
Santiago ÁvilaRíos,
Claudia GarcíaMorales,
Marisol Valenzuela-Lara,
Antoine Chaillon,
Daniela TapiaTrejo,
Marissa PérezGarcía,
Dulce M López-Sánchez,
Liliana Maza-Sánchez,
Silvia J Del Arenal-Sánchez,
Héctor E Paz-Juárez,
Verónica S QuirozMorales,
Sanjay R. Mehta,
Davey M. Smith,
Eddie A León-Juárez,
Carlos Magis-Rodríguez,
Gustavo ReyesTerán
Publication year - 2018
Publication title -
the journal of antimicrobial chemotherapy/journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky512
Subject(s) - demography , drug resistance , hiv drug resistance , medicine , sanger sequencing , human immunodeficiency virus (hiv) , public health , geography , antiretroviral therapy , viral load , virology , biology , genetics , mutation , nursing , sociology , gene
HIV pretreatment drug resistance (PDR) to NNRTIs in persons initiating ART is increasing in Mexico.